Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Symptom Control With THC or CBD Use

NCT04875286 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04875286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Symptom Control With THC or CBD Use
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
February 3, 2021
Completion date
February 2, 2027
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-associated pain, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm